TVGN
What one share of Tevogen holds
Biological Products, (No Diagnostic Substances)
Tevogen’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$6.32 |
|---|---|
| Cash and investments | $0.25 |
| Book value | −$2.09 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$122.17 | $0.27 | −$16.77 | — | — |
| 2024 | — | −$3.50 | — | — | — | −$1.87 |
| 2025 | — | −$8.08 | $0.02 | −$3.73 | — | −$2.05 |
Common questions about Tevogen
How much does one share of Tevogen earn?
Over the last 12 months, Tevogen lost $6.32 for each share.
Does Tevogen pay a dividend?
Tevogen didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Tevogen’s book value per share?
Tevogen’s book value is negative (−$2.09 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Tevogen have?
Each share of Tevogen has $0.25 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.